
Producing Knowledge to Cure Disease
The Feinstein Institutes for Medical Research is Northwell Health’s research enterprise and home to five major research institutes and numerous centers of excellence of national standing. Along with our partners in government, academia, industry and philanthropy, we pursue getting new therapies and therapeutic methods into the hands of doctors and their patients as quickly as possible.
Our work is transforming the treatment of conditions like Crohn’s disease, lupus, rheumatoid arthritis, sepsis, cancer, acute psychiatric illness and Alzheimer’s disease. And we are the world’s scientific headquarters for bioelectronic medicine, an emerging field born in our laboratories that combines neuroscience, molecular medicine and bioengineering to tap into the nervous system in order to treat disease and injury without pharmaceuticals.
With labs and clinical trials located across Northwell Health’s 23 hospitals throughout the New York metropolitan area, we are a cornerstone of the advanced care provided by Northwell—solving the health challenges of today and shaping a better tomorrow.
We rank among the nation’s leaders in terms of NIH grants per researcher. Every year, more than 15,000 patients participate in over 2,000 research studies.
Join us for a career where medical research and technology meet on the road to making new discoveries that cure diseases.
Our careers include opportunities in the fields of:
- Administration
- Biostatistics and data analytics
- Electrical Engineer
- Investigator
- Post Doc Research Trainee (RI)
- Research Scientist


5 STEM healthcare careers for students to explore

From Assistant Clinical Analyst to AVP of the Office of Research Compliance – my career journey

We’re sending shock waves throughout the medical world.

Unleashing the Power of Bioelectronic Medicine.

Turning a dream into reality - the birth of 3D bioprinting
Our research institutes leaders
We are the home to five leading institutes in medical research—each with impressive track records of producing knowledge that cures disease and improves patients’ lives.
Behavioral Health
Led by Dr. John Kane
We are recognized as a world leader in research for effective treatments of debilitating mental health disorders. Our early treatment and comprehensive care programs for patients suffering from first-episode psychosis are national models of best practice research and care in the field.
Bioelectronic Medicine
Led by Dr. Yousef Al-Abed
Our mission as the global headquarters of bioelectronic medicine is to challenge traditional approaches to treatment by generating knowledge and expertise about tapping neural pathways to develop new technologies that provide safe, secure and efficient therapies with few adverse effects.
Cancer Research
Led by Dr. Jeff Boyd
We research cancer and related aspects of cell biology to understand the abnormal growth and behavior of cells that have been malignantly transformed. This information is used to develop and test new diagnostics and treatments for patients suffering from several types of cancers.
Health Innovations & Outcomes Research
Led by Dr. Thomas McGinn
Our research uses epidemiology, statistics and laboratory trials to uncover ways to improve how we deliver care. We examine all levels of healthcare delivery and contribute to developing clinical practice improvements, reducing disparities and healthcare costs.
Molecular Medicine
Led by Dr. Betty Diamond
Our mission is to be a world leader in molecular medicine and the premier entity for the education of disease-focused molecular scientists by conducting outstanding, groundbreaking research directed at understanding molecular mechanisms of disease to promote cures.
Behavioral Health
Behavioral Health
Led by Dr. John Kane
We are recognized as a world leader in research for effective treatments of debilitating mental health disorders. Our early treatment and comprehensive care programs for patients suffering from first-episode psychosis are national models of best practice research and care in the field.
Bioelectronic Medicine
Bioelectronic Medicine
Led by Dr. Yousef Al-Abed
Our mission as the global headquarters of bioelectronic medicine is to challenge traditional approaches to treatment by generating knowledge and expertise about tapping neural pathways to develop new technologies that provide safe, secure and efficient therapies with few adverse effects.
Cancer Research
Cancer Research
Led by Dr. Jeff Boyd
We research cancer and related aspects of cell biology to understand the abnormal growth and behavior of cells that have been malignantly transformed. This information is used to develop and test new diagnostics and treatments for patients suffering from several types of cancers.
Health Innovations & Outcomes Research
Health Innovations & Outcomes Research
Led by Dr. Thomas McGinn
Our research uses epidemiology, statistics and laboratory trials to uncover ways to improve how we deliver care. We examine all levels of healthcare delivery and contribute to developing clinical practice improvements, reducing disparities and healthcare costs.
Molecular Medicine
Molecular Medicine
Led by Dr. Betty Diamond
Our mission is to be a world leader in molecular medicine and the premier entity for the education of disease-focused molecular scientists by conducting outstanding, groundbreaking research directed at understanding molecular mechanisms of disease to promote cures.
Did you know we have…
New York was the epicenter of Covid-19 cases in March and April of 2020, and the Feinstein Institutes addressed the pandemic with speed and excellence. Within a month, our staff worked tirelessly to lay the groundwork to enroll more than 1,200 patients in seven clinical trials and programs, produce our own equipment using 3D design and print techniques developed in our labs, and publish the first and largest dataset in the world of Covid-19 patients.
The Feinstein Institutes joined national network formed by Mayo Clinic to collect convalescent plasma from patients previously identified with COVID-19, but no longer symptomatic
Haichao Wang, PhD, published in Science Translational Medicine his antibody research that may help prevent sepsis induced by Covid-19.
Kenar D. Jhaveri, MD, published in Kidney International that an “alarming number” of hospitalized Covid-19 patients develop acute kidney injury – rates higher than reported from China.
Christina Brennan, MD, MBA, joined the Society for Clinical Research Sites’ Leadership Council.
Stavros Zanos, MD, PhD, and team published a bioelectronic medicine paper in Scientific Reports showing that a specific method of electrical nerve stimulation called anodal block can be leveraged for directional vagus nerve stimulation (VNS).
Professor Todd Lencz, PhD, in collaboration with The Hebrew University of Jerusalem, evaluates the probability of using contemporary genetic technology to select human embryos on the basis of complex traits, such as intelligence and height. The researchers concluded that embryo screening and selection for such features, which are shaped by the action of hundreds or even thousands of genes, are not plausible for the foreseeable future.
Chad Bouton, professor in the Institute of Bioelectronic Medicine, and his team partner with Milad Alizadeh-Meghrazi, director of research and development at Myant Inc. found new closed-loop neurostimulation methods and textile-based electrodes to facilitate individual finger movement and grasp force regulation in quadriplegia individuals.
The Institute of Cancer Research is awarded a five-year, $4.6 million National Cancer Institute (NCI) Community Oncology Research Program (NCORP) grant. The Feinstein Institutes was one of only 32 institutions nationwide to receive funding from this prestigious program – and Northwell’s Cancer Institute was the only cancer center in the tri-state area to participate.
Betty Diamond, MD, and her colleagues reveal new insight into pro-inflammatory macrophages and their relation to autoimmune diseases, as published in the journal Proceedings of the National Academy of Sciences of the US (PNAS).
John M. Kane, MD, and Delbert G. Robinson, MD, are awarded a five-year, $7.3 million National Institutes of Mental Health (NIMH) grant to support their research in improved schizophrenia treatment. The grant – the largest awarded to Northwell Health in 2019 – supports their study titled “Early-phase Schizophrenia: Practice-based Research to Improve Treatment Outcomes (ESPRITO).”
The Public Library of Science Magazine, known as PLOS Biology, notes 26 Feinstein Institutes researchers in a paper assessing the impact of published research from the top 100,000 scientists in the world. Kevin J. Tracey, MD, John Kane, MD, and Peter Davies, PhD, are listed among the elite top 1,000 or .01 percent worldwide.
Bruce T. Volpe, MD, and his colleagues are the first to publish clinical trial results of an investigational, non-invasive medical device for the treatment of spasticity in patients having experienced a stroke.
The Feinstein Institutes for Medical Research at Northwell Health presented data showing the effective use of a long-term vagus nerve implant in mice at the North American Neuromodulation Society (NANS) 2020 Conference, an approach that may become the standard for bioelectronic medicine research conducted around the world.
Professor Valentin A. Pavlov, PhD, is appointed vice-president of the International Society for Autonomic Neuroscience (ISAN) in recognition of his efforts in bioelectronic medicine.
Professor and Senior Vice President Karina W. Davidson, PhD, MASc, finds that systematic depression screening for survivors of acute coronary syndromes did not demonstrate patient benefit. The findings run counter to recommendations from professional societies and is based on results from a randomized clinical trial that included 1,500 survivors of acute coronary syndromes.
Key news stories
Our visionary research leaders are delivering life-changing discoveries every day.
Research careers
We’re proud to contribute to the ongoing success of our people and we’re excited to share some of their stories of growth and advancement.



Director,
Service Line Development,
The Feinstein Institutes for Medical Research
Administrative Manager,
Research,
The Feinstein Institutes for Medical Research
Administrative Project Coordinator,
The Feinstein Institutes for Medical Research
Research Compliance and Institutional Review Board Manager,
The Feinstein Institutes for Medical Research
Institutional Review Board Coordinator,
The Feinstein Institutes for Medical Research
Assistant Vice President,
Technology,
Krasnoff Quality Management Institute
Manager,
Application Development,
Krasnoff Quality Management Institute
Senior Research Data Analyst,
Krasnoff Quality Management Institute
Research Coordinator,
Division of
Hematology/Oncology,
Monter Cancer Center
Assistant Research Coordinator,
Division of
Hematology/Oncology,
Cohen Children’s Medical Center
Meredith Burcyk
Director,
Service Line Development,
Feinstein Institutes for Medical Research
Administrative Manager,
Research,
The Feinstein Institutes for Medical Research
Administrative Project Coordinator,
The Feinstein Institutes for Medical Research
Research Compliance and Institutional Review Board Manager,
The Feinstein Institutes for Medical Research
Institutional Review Board Coordinator,
The Feinstein Institutes for Medical Research
Mohamad Salimi
AVP,
Application Development,
Krasnoff Quality Management Institute
Manager, Applications Development,
Krasnoff Quality Management Institute
Senior Research Data Analyst, Krasnoff Quality Management Institute
Carolyn Pellizzari
Research Coordinator,
Division of Hematology/Oncology,
Monter Cancer Center
Assistant Research Coordinator,
Division of Hematology/Oncology,
Cohen Children’s Medical Center
If you are an individual with a disability requesting an accommodation for the application process, please click the contact us link above to request assistance.
© 2021 - Northwell Health
Click here to view the “EEO is the law” poster.